Oxysterols as non-genomic regulators of cholesterol homeostasis

Trends in Endocrinology and Metabolism

Volumn 23, Issue 3, 2012, Pages 99-106

  Bielska, Agata A ^a   Schlesinger, Paul ^a   Covey, Douglas F ^a   Ory, Daniel S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

22 HYDROXYCHOLESTEROL; 25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; 7 OXOCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL DERIVATIVE; DIOLEOYLPHOSPHATIDYLCHOLINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIVER X RECEPTOR; OXYSTEROL DERIVATIVE; REACTIVE OXYGEN METABOLITE; STEROL REGULATORY ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL MEMBRANE FLUIDITY; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CHOLESTEROL ESTERIFICATION; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; ENDOPLASMIC RETICULUM STRESS; HUMAN; LIPID COMPOSITION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; CHOLESTEROL; GENOMICS; HOMEOSTASIS; OXYGEN; STEROLS;

EID: 84857686547     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2011.12.002     Document Type: Article

References (59)

1. Maxfield F.R., Tabas I. Role of cholesterol and lipid organization in disease. Nature 2005, 438:612-621.
2. Xu X., London E. The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 2000, 39:843-849.
3. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 2002, 110:905-911.
4. Feng B., et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat. Cell Biol. 2003, 5:781-792.
5. Gill S., et al. Sterol regulators of cholesterol homeostasis and beyond: the oxysterol hypothesis revisited and revised. Prog. Lipid Res. 2008, 47:391-404.
6. Janowski B.A., et al. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:266-271.
7. Olkkonen V.M., Hynynen R. Interactions of oxysterols with membranes and proteins. Mol. Aspects Med. 2009, 30:123-133.
8. Schoenheimer F., Breusch F. Synthesis and destruction of cholesterol in the organism. J. Biol. Chem. 1933, 103:439-448.
9. Kandutsch A.A., et al. Biological activity of some oxygenated sterols. Science 1978, 201:498-501.
10. Brown M.S., Goldstein J.L. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J. Lipid Res. 2009, 50(Suppl):S15-S27.
11. Radhakrishnan A., et al. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:6511-6518.
12. Janowski B.A., et al. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996, 383:728-731.
13. Zelcer N., et al. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009, 325:100-104.
14. Lange Y., et al. Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. J. Lipid Res. 1999, 40:2264-2270.
15. Du X., et al. Effects of 25-hydroxycholesterol on cholesterol esterification and sterol regulatory element-binding protein processing are dissociable: implications for cholesterol movement to the regulatory pool in the endoplasmic reticulum. J. Biol. Chem. 2004, 279:47010-47016.
16. Cheng D., et al. Activation of acyl-coenzyme A:cholesterol acyltransferase by cholesterol or by oxysterol in a cell-free system. J. Biol. Chem. 1995, 270:685-695.
17. Lange Y., Steck T.L. Quantitation of the pool of cholesterol associated with acyl-CoA:cholesterol acyltransferase in human fibroblasts. J. Biol. Chem. 1997, 272:13103-13108.
18. Okwu A.K., et al. Regulation of the threshold for lipoprotein-induced acyl-CoA:cholesterol O-acyltransferase stimulation in macrophages by cellular sphingomyelin content. J. Lipid Res. 1994, 35:644-655.
19. Lange Y., et al. Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase. J. Biol. Chem. 2008, 283:1445-1455.
20. Song B.L., et al. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab. 2005, 1:179-189.
21. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature 1990, 343:425-430.
22. Jo Y., Debose-Boyd R. Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase. Crit. Rev. Biochem. Mol. Biol. 2010, 45:185-198.
23. Ohvo-Rekila H., et al. Cholesterol interactions with phospholipids in membranes. Prog. Lipid Res. 2002, 41:66-97.
24. Bloom M., et al. Physical properties of the fluid lipid-bilayer component of cell membranes: a perspective. Q. Rev. Biophys. 1991, 24:293-397.
25. Gale S.E., et al. Side chain oxygenated cholesterol regulates cellular cholesterol homeostasis through direct sterol-membrane interactions. J. Biol. Chem. 2009, 284:1755-1764.
26. Olsen B.N., et al. Perturbations of membrane structure by cholesterol and cholesterol derivatives are determined by sterol orientation. J. Am. Chem. Soc. 2009, 131:4854-4865.
27. Westover E.J., Covey D.F. The enantiomer of cholesterol. J. Membr. Biol. 2004, 202:61-72.
28. Steck T.L., Lange Y. Cell cholesterol homeostasis: mediation by active cholesterol. Trends Cell Biol. 2010, 20:680-687.
29. Hyslop P.A., et al. Organization and interaction of cholesterol and phosphatidylcholine in model bilayer membranes. Biochemistry 1990, 29:1025-1038.
30. Radhakrishnan A., McConnell H.M. Chemical activity of cholesterol in membranes. Biochemistry 2000, 39:8119-8124.
31. Wang J., et al. Relationship between sterol/steroid structure and participation in ordered lipid domains (lipid rafts): implications for lipid raft structure and function. Biochemistry 2004, 43:1010-1018.
32. Huang J., Feigenson G.W. A microscopic interaction model of maximum solubility of cholesterol in lipid bilayers. Biophys. J. 1999, 76:2142-2157.
33. Mesmin B., Maxfield F.R. Intracellular sterol dynamics. Biochim. Biophys. Acta 2009, 1791:636-645.
34. Lange Y., Steck T.L. Cholesterol homeostasis and the escape tendency (activity) of plasma membrane cholesterol. Prog. Lipid Res. 2008, 47:319-332.
35. Haynes M.P., et al. Efflux of cholesterol from different cellular pools. Biochemistry 2000, 39:4508-4517.
36. Slotte J.P., Bierman E.L. Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem. J. 1988, 250:653-658.
37. Lange Y., et al. How cholesterol homeostasis is regulated by plasma membrane cholesterol in excess of phospholipids. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11664-11667.
38. Lange Y., et al. Regulation of fibroblast mitochondrial 27-hydroxycholesterol production by active plasma membrane cholesterol. J. Lipid Res. 2009, 50:1881-1888.
39. Lange Y., et al. Activation of membrane cholesterol by displacement from phospholipids. J. Biol. Chem. 2005, 280:36126-36131.
40. Olsen B.N., et al. Side-chain oxysterols: from cells to membranes to molecules. Biochim. Biophys. Acta 2011, 10.1016/j.bbamem.2011.06.014.
41. Flanagan J.J., et al. Cholesterol exposure at the membrane surface is necessary and sufficient to trigger perfringolysin O binding. Biochemistry 2009, 48:3977-3987.
42. Nelson L.D., et al. How interaction of perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological low pH: insights into the origin of perfringolysin O-lipid raft interaction. J. Biol. Chem. 2008, 283:4632-4642.
43. Ramachandran R., et al. Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. Nat. Struct. Biol. 2002, 9:823-827.
44. Radhakrishnan A., et al. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab. 2008, 8:512-521.
45. Sokolov A., Radhakrishnan A. Accessibility of cholesterol in endoplasmic reticulum (ER) membranes and activation of SREBP-2 switch abruptly at a common cholesterol threshold. J. Biol. Chem. 2010, 1-20.
46. Brown A.J., et al. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol. Cell 2002, 10:237-245.
47. Radhakrishnan A., et al. Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain. Mol. Cell 2004, 15:259-268.
48. Sun L.P., et al. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:6519-6526.
49. Bjorkhem I. Do oxysterols control cholesterol homeostasis?. J. Clin. Invest. 2002, 110:725-730.
50. Raychaudhuri S., Prinz W.A. The diverse functions of oxysterol-binding proteins. Annu. Rev. Cell Dev. Biol. 2010, 26:157-177.
51. Schulz T.A., et al. Lipid-regulated sterol transfer between closely apposed membranes by oxysterol-binding protein homologues. J. Cell Biol. 2009, 187:889-903.
52. Borradaile N.M., et al. Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J. Lipid Res. 2006, 47:2726-2737.
53. Li Y., et al. Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids: implications for depletion of endoplasmic reticulum calcium stores and apoptosis in cholesterol-loaded macrophages. J. Biol. Chem. 2004, 279:37030-37039.
54. Cui D., et al. Pivotal advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells. J. Leukoc. Biol. 2007, 82:1040-1050.
55. Thorp E., Tabas I. Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J. Leukoc. Biol. 2009, 86:1089-1095.
56. Westman J., et al. Sterol 27-hydroxylase- and apoAI/phospholipid-mediated efflux of cholesterol from cholesterol-laden macrophages. Arterioscler. Thromb. Vasc. Biol. 1998, 18:554-561.
57. Lundbaek J.A., et al. Cholesterol-induced protein sorting: an analysis of energetic feasibility. Biophys. J. 2003, 84:2080-2089.
58. Westover E.J., et al. Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. Studies with cholesterol enantiomers. J. Biol. Chem. 2003, 278:51125-51133.
59. Lee A.G. How lipids affect the activities of integral membrane proteins. Biochim. Biophys. Acta 2004, 1666:62-87.